Dr. Jeffrey R. Jay, M.D. »

Enliven Therapeutics shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.6M 70k 50.75

More positions owned by Dr. Jeffrey R. Jay, M.D.

Abivax Sa Sponsored Ads (ABVX)
Vor Biopharma Com New (VOR)
Immunitybio Put Option (IBRX)
Vera Therapeutics Cl A (VERA)
Zura Bio Class A Ord Shs (ZURA)
Alumis (ALMS)
Sol-gel Technologies Shs New (SLGL)
Ultragenyx Pharmaceutical Put Option (RARE)
Definium Therapeutics Com Shs (DFTX)
Annexon (ANNX)
Oruka Therapeutics (ORKA)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Sagimet Biosciences Com Ser A (SGMT)
Contineum Therapeutics Cl A (CTNM)
Immix Biopharma (IMMX)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Enliven Therapeutics

FMR
OrbiMed Advisors
Polar Capital Holdings
BlackRock
Vestal Point Capital
Commodore Capital
Vanguard Capital Management
Citadel Advisors
Fairmount Funds Management
Siren
Bellevue Group
Geode Capital Management
First Light Asset Management
Pictet Asset Management Holding SA
State Street Corporation

View all funds holding Enliven Therapeutics